ArticleClinical & developmental immunology2013

Assessment of T regulatory cells and expanded profiling of autoantibodies may offer novel biomarkers for the clinical management of systemic sclerosis and undifferentiated connective tissue disease.

Paola Cordiali-Fei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.